Francisco German Rodriguez Gonzalez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Francisco German Rodriguez Gonzalez has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Bonifacio Nicolas Díaz-Chico
Department of Biochemistry and Physiology, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
15 shared publications - Juan Carlos Díaz Chico
Endometrial Cancer Study Group, Instituto Canario de Investigación del Cáncer (ICIC), Canary Islands, Spain
9 shared publications - Cristina Bilbao-Sieyro
Hospital Universitario de Gran Canaria Dr. Negrín, Instituto de Investigación Sanitaria de Canarias (IISC), Las Palmas De Gran Canaria, Spain
7 shared publications - Amelia Guadalupe-Grau
Growth, Exercise, Nutrition and Development (GENUD) Toledo Research Group, Faculty of Sport Sciences, University of Castilla-La Mancha, 45071 Toledo, Spain
6 shared publications Anieta M. Sieuwerts
6 shared publications- Cecilia Dorado
Department of Physical Education, University of Las Palmas de Gran Canaria, Canary Islands, Spain
6 shared publications
Latest Publications
- Open Access
- 19 March 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 28 (6) , 1442-1457
Combined patch-clamp electrophysiology and single-cell genomic analysis reveal spiking tumor cells at the neocortical glioblastoma interface in humans
Background: Electrophysiological features of glioblastoma cells (GBCs) remain largely elusive, challenging our comprehension of glioblastoma pathophysiology. Spiking GABAergic-oligodendrocyte-progenitor (OPC) tumor cells were recently described in IDH-mutant glioma, correlating with prolonged patient survival. Here, we characterize single-cell features at the neocortical leading edge (LE) of glioblastoma patients using combined electrophysiological, morphological, and transcriptomic profiling. Methods: We examined GBCs and non-tumor cells using acute and cultured organotypic slices of cancer-infiltrated neocortical tissues from glioblastoma patients. Electrophysiological properties of LE cells were investigated using whole-cell patch-clamp recording, with dye loading to characterize single-cell morphology. We used Patch-seq to determine the transcriptomic features of recorded LE cells and discriminate tumor and non-tumor cells, followed by gene set enrichment analysis and CellChat to identify differential gene expression and signaling. Results: Upon depolarization, more than half of LE cells show aberrant action potentials (aAPs), akin to neurodevelopmental cells. Reconstructed LE cells have abnormal somatodendritic morphology. Patch-seq revealed that GBCs and non-tumor cells share a similar electrophysiological phenotype, including aAP generation, depolarized membrane potential, and elevated input resistance. Transcriptomic analysis shows that the aAP phenotype occurs across diverse GBC states and correlates with lower enrichment of proliferation-related pathways at the single-cell level, but higher enrichment of inflammatory/immune, angiogenic, and mesenchymal transition pathways. Non-tumor cells exhibit hybrid transcriptomic signatures, with predominantly neuronal but minor enrichment of astrocytic features. Conclusion: We find electrophysiological aAP behavior of GBCs in human glioblastoma, closely resembling that of hybrid cells in IDH-mutant glioma, supporting the hypothesis of neuronal mimicry across different glioma types.
- 19 March 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 28 (6) , 1442-1457
Open AccessCombined patch-clamp electrophysiology and single-cell genomic analysis reveal spiking tumor cells at the neocortical glioblastoma interface in humans
Background: Electrophysiological features of glioblastoma cells (GBCs) remain largely elusive, challenging our comprehension of glioblastoma pathophysiology. Spiking GABAergic-oligodendrocyte-progenitor (OPC) tumor cells were recently described in IDH-mutant glioma, correlating with prolonged patient survival. Here, we characterize single-cell features at the neocortical leading edge (LE) of glioblastoma patients using combined electrophysiological, morphological, and transcriptomic profiling. Methods: We examined GBCs and non-tumor cells using acute and cultured organotypic slices of cancer-infiltrated neocortical tissues from glioblastoma patients. Electrophysiological properties of LE cells were investigated using whole-cell patch-clamp recording, with dye loading to characterize single-cell morphology. We used Patch-seq to determine the transcriptomic features of recorded LE cells and discriminate tumor and non-tumor cells, followed by gene set enrichment analysis and CellChat to identify differential gene expression and signaling. Results: Upon depolarization, more than half of LE cells show aberrant action potentials (aAPs), akin to neurodevelopmental cells. Reconstructed LE cells have abnormal somatodendritic morphology. Patch-seq revealed that GBCs and non-tumor cells share a similar electrophysiological phenotype, including aAP generation, depolarized membrane potential, and elevated input resistance. Transcriptomic analysis shows that the aAP phenotype occurs across diverse GBC states and correlates with lower enrichment of proliferation-related pathways at the single-cell level, but higher enrichment of inflammatory/immune, angiogenic, and mesenchymal transition pathways. Non-tumor cells exhibit hybrid transcriptomic signatures, with predominantly neuronal but minor enrichment of astrocytic features. Conclusion: We find electrophysiological aAP behavior of GBCs in human glioblastoma, closely resembling that of hybrid cells in IDH-mutant glioma, supporting the hypothesis of neuronal mimicry across different glioma types.
- Open Access
- 20 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (8) , eadv4540
Hemizygous loss of helicases promotes genomic instability and cancer development
Cancer mutations perturb key processes, driving uncontrolled cell proliferation. With critical roles of enzymes in cell function and growth, we hypothesized that cancer driver mutations alter specific and recurrent enzymatic functions. Leveraging large pan-cancer genomic datasets and curated mutation catalogs, we identified frequent mutations in helicases, enzymes involved in nucleic acid unwinding and processing. Helicases emerged as the most commonly mutated cancer driver enzyme family, altered in two-thirds of all cancers. Functional screens and genomic analyses revealed that helicase dysfunctions contribute to genomic instability and faulty DNA repair. We observed a marked phenotype of Aquarius helicase ( AQR ), which was recurrently hemizygously deleted as an early clonal event in cancer genomes. These deletions were associated with high genomic instability and homologous recombination deficiency signatures. Furthermore, we found hemizygous loss to be a common tumor suppression mechanism among helicases, present in 35% of all cancers. Overall, our enzyme-family approach highlights helicases, including AQR , as key potential cancer drivers.
- 20 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (8) , eadv4540
Open AccessHemizygous loss of helicases promotes genomic instability and cancer development
Cancer mutations perturb key processes, driving uncontrolled cell proliferation. With critical roles of enzymes in cell function and growth, we hypothesized that cancer driver mutations alter specific and recurrent enzymatic functions. Leveraging large pan-cancer genomic datasets and curated mutation catalogs, we identified frequent mutations in helicases, enzymes involved in nucleic acid unwinding and processing. Helicases emerged as the most commonly mutated cancer driver enzyme family, altered in two-thirds of all cancers. Functional screens and genomic analyses revealed that helicase dysfunctions contribute to genomic instability and faulty DNA repair. We observed a marked phenotype of Aquarius helicase ( AQR ), which was recurrently hemizygously deleted as an early clonal event in cancer genomes. These deletions were associated with high genomic instability and homologous recombination deficiency signatures. Furthermore, we found hemizygous loss to be a common tumor suppression mechanism among helicases, present in 35% of all cancers. Overall, our enzyme-family approach highlights helicases, including AQR , as key potential cancer drivers.
- 28 May 2020
- Published by American Society of Hematology in Blood
- Vol. 135 (22) , 2000-2004
Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL
Eskelund et al examined clonal hematopoiesis (CH) in a cohort of patients with mantle cell lymphoma (MCL) treated with first-line chemotherapy and autologous stem cell transplantation. In young, good-risk MCL patients, CH after first-line therapy arises almost entirely from preexisting clones, stabilizes after a period of expansion posttransplantation, and does not negatively impact survival.
- 28 May 2020
- Published by American Society of Hematology in Blood
- Vol. 135 (22) , 2000-2004
Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL
Eskelund et al examined clonal hematopoiesis (CH) in a cohort of patients with mantle cell lymphoma (MCL) treated with first-line chemotherapy and autologous stem cell transplantation. In young, good-risk MCL patients, CH after first-line therapy arises almost entirely from preexisting clones, stabilizes after a period of expansion posttransplantation, and does not negatively impact survival.
- 20 March 2020
- Published by Springer Nature in Leukemia
- Vol. 34 (12) , 3256-3268
Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study
Clonal hematopoiesis of indeterminate potential (CHIP) is suspected of being a risk factor for patients with cancer. This study aimed to assess the clinical consequences of CHIP in patients with lymphoma intended for high-dose chemotherapy and autologous stem-cell transplantation (ASCT) in a population-based setting. We identified 892 lymphoma patients who had undergone stem cell harvest at all transplant centers in Denmark. A total of 565 patients had an available harvest sample, which was analysed for CHIP by next-generation sequencing, and the median follow-up was 9.1 years. Of the patients who were intended for immediate ASCT, 25.5% (112/440) carried at least one CHIP mutation. In contrast to previous single-center studies CHIP was not associated with inferior overall survival (OS) in multivariate analyses. However, patients with mutations in genes of the DNA repair pathway (PPM1D, TP53, RAD21, BRCC3) had a significant inferior OS (HR after 1 year of follow-up 2.79, 95% confidence interval 1.71–4.56; p < 0.0001), which also was evident in multivariate analysis (p = 0.00067). These patients had also increased rates of therapy-related leukemia and admission to intensive care. Furthermore, in patients who did not undergo immediate ASCT, a significant inferior OS of individuals with DNA repair mutations was also identified (p = 0.003).
- 20 March 2020
- Published by Springer Nature in Leukemia
- Vol. 34 (12) , 3256-3268
Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study
Clonal hematopoiesis of indeterminate potential (CHIP) is suspected of being a risk factor for patients with cancer. This study aimed to assess the clinical consequences of CHIP in patients with lymphoma intended for high-dose chemotherapy and autologous stem-cell transplantation (ASCT) in a population-based setting. We identified 892 lymphoma patients who had undergone stem cell harvest at all transplant centers in Denmark. A total of 565 patients had an available harvest sample, which was analysed for CHIP by next-generation sequencing, and the median follow-up was 9.1 years. Of the patients who were intended for immediate ASCT, 25.5% (112/440) carried at least one CHIP mutation. In contrast to previous single-center studies CHIP was not associated with inferior overall survival (OS) in multivariate analyses. However, patients with mutations in genes of the DNA repair pathway (PPM1D, TP53, RAD21, BRCC3) had a significant inferior OS (HR after 1 year of follow-up 2.79, 95% confidence interval 1.71–4.56; p < 0.0001), which also was evident in multivariate analysis (p = 0.00067). These patients had also increased rates of therapy-related leukemia and admission to intensive care. Furthermore, in patients who did not undergo immediate ASCT, a significant inferior OS of individuals with DNA repair mutations was also identified (p = 0.003).
- Top Cited PapersOpen Access
- 5 February 2020
- Published by Springer Nature in Nature
- Vol. 578 (7793) , 82-93
Pan-cancer analysis of whole genomes
Cancer is driven by genetic change, and the advent of massively parallel sequencing has enabled systematic documentation of this variation at the whole-genome scale1–3. Here we report the integrative analysis of 2,658 whole-cancer genomes and their matching normal tissues across 38 tumour types from the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium of the International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA). We describe the generation of the PCAWG resource, facilitated by international data sharing using compute clouds. On average, cancer genomes contained 4–5 driver mutations when combining coding and non-coding genomic elements; however, in around 5% of cases no drivers were identified, suggesting that cancer driver discovery is not yet complete. Chromothripsis, in which many clustered structural variants arise in a single catastrophic event, is frequently an early event in tumour evolution; in acral melanoma, for example, these events precede most somatic point mutations and affect several cancer-associated genes simultaneously. Cancers with abnormal telomere maintenance often originate from tissues with low replicative activity and show several mechanisms of preventing telomere attrition to critical levels. Common and rare germline variants affect patterns of somatic mutation, including point mutations, structural variants and somatic retrotransposition. A collection of papers from the PCAWG Consortium describes non-coding mutations that drive cancer beyond those in the TERT promoter4; identifies new signatures of mutational processes that cause base substitutions, small insertions and deletions and structural variation5,6; analyses timings and patterns of tumour evolution7; describes the diverse transcriptional consequences of somatic mutation on splicing, expression levels, fusion genes and promoter activity8,9; and evaluates a range of more-specialized features of cancer genomes8,10–18.
- 5 February 2020
- Published by Springer Nature in Nature
- Vol. 578 (7793) , 82-93
Top Cited PapersOpen AccessPan-cancer analysis of whole genomes
Cancer is driven by genetic change, and the advent of massively parallel sequencing has enabled systematic documentation of this variation at the whole-genome scale1–3. Here we report the integrative analysis of 2,658 whole-cancer genomes and their matching normal tissues across 38 tumour types from the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium of the International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA). We describe the generation of the PCAWG resource, facilitated by international data sharing using compute clouds. On average, cancer genomes contained 4–5 driver mutations when combining coding and non-coding genomic elements; however, in around 5% of cases no drivers were identified, suggesting that cancer driver discovery is not yet complete. Chromothripsis, in which many clustered structural variants arise in a single catastrophic event, is frequently an early event in tumour evolution; in acral melanoma, for example, these events precede most somatic point mutations and affect several cancer-associated genes simultaneously. Cancers with abnormal telomere maintenance often originate from tissues with low replicative activity and show several mechanisms of preventing telomere attrition to critical levels. Common and rare germline variants affect patterns of somatic mutation, including point mutations, structural variants and somatic retrotransposition. A collection of papers from the PCAWG Consortium describes non-coding mutations that drive cancer beyond those in the TERT promoter4; identifies new signatures of mutational processes that cause base substitutions, small insertions and deletions and structural variation5,6; analyses timings and patterns of tumour evolution7; describes the diverse transcriptional consequences of somatic mutation on splicing, expression levels, fusion genes and promoter activity8,9; and evaluates a range of more-specialized features of cancer genomes8,10–18.
- Open Access
- 15 April 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-10
Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation
Global loss of DNA methylation and CpG island (CGI) hypermethylation are key epigenomic aberrations in cancer. Global loss manifests itself in partially methylated domains (PMDs) which extend up to megabases. However, the distribution of PMDs within and between tumor types, and their effects on key functional genomic elements including CGIs are poorly defined. We comprehensively show that loss of methylation in PMDs occurs in a large fraction of the genome and represents the prime source of DNA methylation variation. PMDs are hypervariable in methylation level, size and distribution, and display elevated mutation rates. They impose intermediate DNA methylation levels incognizant of functional genomic elements including CGIs, underpinning a CGI methylator phenotype (CIMP). Repression effects on tumor suppressor genes are negligible as they are generally excluded from PMDs. The genomic distribution of PMDs reports tissue-of-origin and may represent tissue-specific silent regions which tolerate instability at the epigenetic, transcriptomic and genetic level.
- 15 April 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-10
Open AccessPartially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation
Global loss of DNA methylation and CpG island (CGI) hypermethylation are key epigenomic aberrations in cancer. Global loss manifests itself in partially methylated domains (PMDs) which extend up to megabases. However, the distribution of PMDs within and between tumor types, and their effects on key functional genomic elements including CGIs are poorly defined. We comprehensively show that loss of methylation in PMDs occurs in a large fraction of the genome and represents the prime source of DNA methylation variation. PMDs are hypervariable in methylation level, size and distribution, and display elevated mutation rates. They impose intermediate DNA methylation levels incognizant of functional genomic elements including CGIs, underpinning a CGI methylator phenotype (CIMP). Repression effects on tumor suppressor genes are negligible as they are generally excluded from PMDs. The genomic distribution of PMDs reports tissue-of-origin and may represent tissue-specific silent regions which tolerate instability at the epigenetic, transcriptomic and genetic level.
- Open Access
- 28 January 2019
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 29 (3) , 356-366
The circular RNome of primary breast cancer
Circular RNAs (circRNAs) are a class of RNAs that is under increasing scrutiny, although their functional roles are debated. We analyzed RNA-seq data of 348 primary breast cancers and developed a method to identify circRNAs that does not rely on unmapped reads or known splice junctions. We identified 95,843 circRNAs, of which 20,441 were found recurrently. Of the circRNAs that match exon boundaries of the same gene, 668 showed a poor or even negative (R < 0.2) correlation with the expression level of the linear gene. In silico analysis showed only a minority (8.5%) of circRNAs could be explained by known splicing events. Both these observations suggest that specific regulatory processes for circRNAs exist. We confirmed the presence of circRNAs of CNOT2, CREBBP, and RERE in an independent pool of primary breast cancers. We identified circRNA profiles associated with subgroups of breast cancers and with biological and clinical features, such as amount of tumor lymphocytic infiltrate and proliferation index. siRNA-mediated knockdown of circCNOT2 was shown to significantly reduce viability of the breast cancer cell lines MCF-7 and BT-474, further underlining the biological relevance of circRNAs. Furthermore, we found that circular, and not linear, CNOT2 levels are predictive for progression-free survival time to aromatase inhibitor (AI) therapy in advanced breast cancer patients, and found that circCNOT2 is detectable in cell-free RNA from plasma. We showed that circRNAs are abundantly present, show characteristics of being specifically regulated, are associated with clinical and biological properties, and thus are relevant in breast cancer.
- 28 January 2019
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 29 (3) , 356-366
Open AccessThe circular RNome of primary breast cancer
Circular RNAs (circRNAs) are a class of RNAs that is under increasing scrutiny, although their functional roles are debated. We analyzed RNA-seq data of 348 primary breast cancers and developed a method to identify circRNAs that does not rely on unmapped reads or known splice junctions. We identified 95,843 circRNAs, of which 20,441 were found recurrently. Of the circRNAs that match exon boundaries of the same gene, 668 showed a poor or even negative (R < 0.2) correlation with the expression level of the linear gene. In silico analysis showed only a minority (8.5%) of circRNAs could be explained by known splicing events. Both these observations suggest that specific regulatory processes for circRNAs exist. We confirmed the presence of circRNAs of CNOT2, CREBBP, and RERE in an independent pool of primary breast cancers. We identified circRNA profiles associated with subgroups of breast cancers and with biological and clinical features, such as amount of tumor lymphocytic infiltrate and proliferation index. siRNA-mediated knockdown of circCNOT2 was shown to significantly reduce viability of the breast cancer cell lines MCF-7 and BT-474, further underlining the biological relevance of circRNAs. Furthermore, we found that circular, and not linear, CNOT2 levels are predictive for progression-free survival time to aromatase inhibitor (AI) therapy in advanced breast cancer patients, and found that circCNOT2 is detectable in cell-free RNA from plasma. We showed that circRNAs are abundantly present, show characteristics of being specifically regulated, are associated with clinical and biological properties, and thus are relevant in breast cancer.
- Open Access
- 14 September 2017
- Published by ARAN Ediciones in Nutrición Hospitalaria
- Vol. 34 (5) , 1089-1098
Androgen receptor gene polymorphisms and maximal fat oxidation in men. A longitudinal study.
Introduction: The aims of this study were i) to evaluate if extreme CAG and GGN repeat polymorphisms of the androgen receptors (AR) influence body fat mass, its regional distribution, resting metabolic rate (RMR), resting and maximal fat oxidation capacity (MFO) and fat tissue accumulation after 6.4 years of follow up and ii) to determine if these differences are explained by changes in maximal oxygen uptake (VO2max).Potential associations between AR polymorphisms and serum concentration of leptin, free testosterone and osteocalcin were also examined. Methods: CAG and GGN repeats length were measured in 319 men (mean±SD: 28.3±7.6 years). From these, we selected the subjects with extreme short (CAGS≤19; n=7) and long (CAGL≥24; n=10) CAG repeats, and the subjects with short (GGNS≤22; n=9) and long (GGNL≥25; n=10) GGN repeats. Results: CAGS and CAGL subjects had similar RMR and accumulated comparable amounts of fat tissue over 6.4 ± 1.0 years of follow-up. However, CAGL showed higher MFO and total lean mass than CAGS (pS accumulated greater amount of total fat mass than men with GGNL, particularly in the trunk region seven years later. This concurs with a trend for a greater MFO in the GGNL group (P=0.06), who accumulated less fat mass. Free testosterone was associated with MFO in absolute values (r=0.45; p<0.05) and MFO per kg of lower extremity lean mass per height squared (r=0.35; p<0.05). Conclusions:CAG and GGN repeats polymorphisms may influence muscle fat oxidation capacity and may have a role in the accumulation of fat over the years.
- 14 September 2017
- Published by ARAN Ediciones in Nutrición Hospitalaria
- Vol. 34 (5) , 1089-1098
Open AccessAndrogen receptor gene polymorphisms and maximal fat oxidation in men. A longitudinal study.
Introduction: The aims of this study were i) to evaluate if extreme CAG and GGN repeat polymorphisms of the androgen receptors (AR) influence body fat mass, its regional distribution, resting metabolic rate (RMR), resting and maximal fat oxidation capacity (MFO) and fat tissue accumulation after 6.4 years of follow up and ii) to determine if these differences are explained by changes in maximal oxygen uptake (VO2max).Potential associations between AR polymorphisms and serum concentration of leptin, free testosterone and osteocalcin were also examined. Methods: CAG and GGN repeats length were measured in 319 men (mean±SD: 28.3±7.6 years). From these, we selected the subjects with extreme short (CAGS≤19; n=7) and long (CAGL≥24; n=10) CAG repeats, and the subjects with short (GGNS≤22; n=9) and long (GGNL≥25; n=10) GGN repeats. Results: CAGS and CAGL subjects had similar RMR and accumulated comparable amounts of fat tissue over 6.4 ± 1.0 years of follow-up. However, CAGL showed higher MFO and total lean mass than CAGS (pS accumulated greater amount of total fat mass than men with GGNL, particularly in the trunk region seven years later. This concurs with a trend for a greater MFO in the GGNL group (P=0.06), who accumulated less fat mass. Free testosterone was associated with MFO in absolute values (r=0.45; p<0.05) and MFO per kg of lower extremity lean mass per height squared (r=0.35; p<0.05). Conclusions:CAG and GGN repeats polymorphisms may influence muscle fat oxidation capacity and may have a role in the accumulation of fat over the years.
- Top Cited PapersOpen Access
- 20 July 2017
- Published by Springer Nature in Nature
- Vol. 547 (7663) , 311-317
The whole-genome landscape of medulloblastoma subtypes
Current therapies for medulloblastoma, a highly malignant childhood brain tumour, impose debilitating effects on the developing child, and highlight the need for molecularly targeted treatments with reduced toxicity. Previous studies have been unable to identify the full spectrum of driver genes and molecular processes that operate in medulloblastoma subgroups. Here we analyse the somatic landscape across 491 sequenced medulloblastoma samples and the molecular heterogeneity among 1,256 epigenetically analysed cases, and identify subgroup-specific driver alterations that include previously undiscovered actionable targets. Driver mutations were confidently assigned to most patients belonging to Group 3 and Group 4 medulloblastoma subgroups, greatly enhancing previous knowledge. New molecular subtypes were differentially enriched for specific driver events, including hotspot in-frame insertions that target KBTBD4 and ‘enhancer hijacking’ events that activate PRDM6. Thus, the application of integrative genomics to an extensive cohort of clinical samples derived from a single childhood cancer entity revealed a series of cancer genes and biologically relevant subtype diversity that represent attractive therapeutic targets for the treatment of patients with medulloblastoma.
- 20 July 2017
- Published by Springer Nature in Nature
- Vol. 547 (7663) , 311-317
Top Cited PapersOpen AccessThe whole-genome landscape of medulloblastoma subtypes
Current therapies for medulloblastoma, a highly malignant childhood brain tumour, impose debilitating effects on the developing child, and highlight the need for molecularly targeted treatments with reduced toxicity. Previous studies have been unable to identify the full spectrum of driver genes and molecular processes that operate in medulloblastoma subgroups. Here we analyse the somatic landscape across 491 sequenced medulloblastoma samples and the molecular heterogeneity among 1,256 epigenetically analysed cases, and identify subgroup-specific driver alterations that include previously undiscovered actionable targets. Driver mutations were confidently assigned to most patients belonging to Group 3 and Group 4 medulloblastoma subgroups, greatly enhancing previous knowledge. New molecular subtypes were differentially enriched for specific driver events, including hotspot in-frame insertions that target KBTBD4 and ‘enhancer hijacking’ events that activate PRDM6. Thus, the application of integrative genomics to an extensive cohort of clinical samples derived from a single childhood cancer entity revealed a series of cancer genes and biologically relevant subtype diversity that represent attractive therapeutic targets for the treatment of patients with medulloblastoma.
- 1 January 2017
- Published by Edizioni Minerva Medica in The Journal of Sports Medicine and Physical Fitness
- Vol. 57 (1-2) , 18-25
Androgen receptor CAG and GGN repeat polymorphisms influence performance in boys and girls
Article: Androgen receptor CAG and GGN repeat polymorphisms influence performance in boys and girls - The Journal of Sports Medicine and Physical Fitness 2017 January-February;57(1-2):18-25 - Minerva Medica - Journals
- 1 January 2017
- Published by Edizioni Minerva Medica in The Journal of Sports Medicine and Physical Fitness
- Vol. 57 (1-2) , 18-25
Androgen receptor CAG and GGN repeat polymorphisms influence performance in boys and girls
Article: Androgen receptor CAG and GGN repeat polymorphisms influence performance in boys and girls - The Journal of Sports Medicine and Physical Fitness 2017 January-February;57(1-2):18-25 - Minerva Medica - Journals